GNMSF Financials
Genmab A/S - Financial statements & key metrics
Stock Price
$281.75
Market Cap
$17.75B
P/E Ratio
18.3
EPS
$15.38
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$3.85B
Gross Profit
$3.53B
Operating Income
$1.29B
Net Income
$996.93M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$12.82B
Total Liabilities
$6.99B
Shareholders Equity
$5.82B
Cash & Equivalents
$1.71B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$1.23B
CapEx
$38.30M
Free Cash Flow
$1.19B
Profitability Metrics
Gross Margin
93.6%
Operating Margin
0.2%
Net Margin
0.3%
ROE
0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is GNMSF revenue?
GNMSF's most recent quarterly revenue was $3.85B. Annual revenue can be calculated by summing the four most recent quarters.
Is GNMSF profitable?
GNMSF reported a profit of $996.93M in the most recent quarter. The net profit margin is 0.3%.
What is GNMSF market cap?
GNMSF has a market capitalization of $17.75B, making it a large-cap stock.
Does GNMSF have debt?
View GNMSF's balance sheet for debt information.
What is GNMSF cash flow?
GNMSF's most recent quarterly free cash flow was $1.19B.